264 related articles for article (PubMed ID: 35372065)
41. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
42. The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer.
Ohtaka T; Ando K; Oike T; Noda SE; Kaminuma T; Murata K; Ohno T
Front Oncol; 2024; 14():1366777. PubMed ID: 38774419
[TBL] [Abstract][Full Text] [Related]
43. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
[TBL] [Abstract][Full Text] [Related]
44. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
45. Clinical outcomes of single application multi-fractionated CT-guided interstitial high-dose-rate brachytherapy for locally advanced cervical cancer: A multi-institution initial experience.
Yap ET; Dumago MP; Jainar CJ; Bojador M; Cabrera SM; Gonzalez GS; Mariano JZ; Bautista A; Mababangloob J; Genson JM; Ortin TS; Bacorro WR
J Contemp Brachytherapy; 2023 Dec; 15(6):399-404. PubMed ID: 38230398
[TBL] [Abstract][Full Text] [Related]
46. Model assessment of individual tumor control rate and adverse effects in comparing locally advanced cervical cancer treatment using intracavitary with and without interstitial brachytherapy.
Kuo HC; Mehta KJ; Yaparpalvi R; Shankar V; Bodner W; Garg M; Rivera A; Tomé WA; Kalnicki S
J Contemp Brachytherapy; 2016 Dec; 8(6):525-532. PubMed ID: 28115959
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study.
Xiu YT; Meng FX; Wang Z; Zhao KK; Wang YL; Chen ZS; Sun BS
J Contemp Brachytherapy; 2022 Aug; 14(4):332-340. PubMed ID: 36199952
[TBL] [Abstract][Full Text] [Related]
48. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
[TBL] [Abstract][Full Text] [Related]
49. Magnetic resonance image-based 3D volume interstitial brachytherapy using polyether ether ketone catheters in advanced cervical cancer - a feasibility study.
Palled SR; Tanvirpasha CAR; Naveen T; Sathiyan S; Kadirampatti G; Lokesh V
J Contemp Brachytherapy; 2019 Aug; 11(4):307-311. PubMed ID: 31523230
[TBL] [Abstract][Full Text] [Related]
50. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP; Lindegaard JC; Mahantshetty U; Tanderup K; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza A; Hoskin P; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Petric P; Ramazanova D; Ristl R; Kannan S; Hawaldar R; Ecker S; Kirchheiner K; Tan LT; Nout R; Nesvacil N; de Leeuw A; Pötter R; Kirisits C;
J Clin Oncol; 2023 Apr; 41(10):1933-1942. PubMed ID: 36599120
[TBL] [Abstract][Full Text] [Related]
51. Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis.
Hermesse J; Pleyers C; Gennigens C; De Cuypere M; Lovinfosse P; Seidel Statistician L; Coucke P; Kridelka F
Strahlenther Onkol; 2023 Feb; 199(2):141-148. PubMed ID: 35943555
[TBL] [Abstract][Full Text] [Related]
52. Effect of bladder volume on radiation doses to organs at risk and tumor in cervical cancer during image-guided adaptive brachytherapy and treatment outcome analysis.
Xu Z; Yang L; Ma L; Liu Q; Chang AT; Zhou Y; Zhou C; Kong FM; Chen L
Mol Clin Oncol; 2021 Dec; 15(6):258. PubMed ID: 34765192
[TBL] [Abstract][Full Text] [Related]
53. Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study.
Faye MD; Petruccelli Araujo M; Wissing MD; Alrabiah K; Gilbert L; Zeng X; Souhami L; Alfieri J
Curr Oncol; 2023 May; 30(5):4966-4978. PubMed ID: 37232833
[TBL] [Abstract][Full Text] [Related]
54. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters.
Chargari C; Mazeron R; Escande A; Maroun P; Dumas I; Martinetti F; Tafo-Guemnie A; Deutsch E; Morice P; Haie-Meder C
Brachytherapy; 2016; 15(4):456-462. PubMed ID: 27180129
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of Computed Tomography-Guided Image-Based Interstitial Brachytherapy for Cancer of the Cervix Using GEC-ESTRO Guidelines.
Rishi KS; Alva RC; Kadam AR; Sharma S
Indian J Surg Oncol; 2018 Jun; 9(2):181-186. PubMed ID: 29887698
[TBL] [Abstract][Full Text] [Related]
56. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
[TBL] [Abstract][Full Text] [Related]
57. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
[TBL] [Abstract][Full Text] [Related]
58. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
[TBL] [Abstract][Full Text] [Related]
59. The Relationship Between Late Morbidity and Dose-Volume Parameter of Rectum in Combined Intracavitary/Interstitial Cervix Cancer Brachytherapy: A Mono-Institutional Experience.
Zhang N; Liu Y; Han D; Guo X; Mao Z; Yang W; Cheng G
Front Oncol; 2021; 11():693864. PubMed ID: 34367976
[TBL] [Abstract][Full Text] [Related]
60. Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes.
Mahantshetty U; Gurram L; Bushra S; Ghadi Y; Aravindakshan D; Paul J; Hande V; Pilar A; Chopra S; Ghosh J; Shylasree TS; Popat P; Sable N; Maheswari A; Gupta S
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):826-834. PubMed ID: 34146636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
